InVitro International (IVRO) Stock Statistics & Valuation Metrics
Total Valuation
InVitro International has a market cap or net worth of $1.33M. The enterprise value is $392.35B.
- Market Cap
- $1.33M
- Enterprise Value
- $392.35B
Share Statistics
InVitro International has 22,159,810 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 22,159,810
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
InVitro International’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 4.42%.
- Return on Equity (ROE)
- 0.07
- Return on Assets (ROA)
- 0.06
- Return on Invested Capital (ROIC)
- 4.42%
- Return on Capital Employed (ROCE)
- 0.05
- Revenue Per Employee
- 175.79K
- Profits Per Employee
- 24.40K
- Employee Count
- 5
- Asset Turnover
- 0.44
- Inventory Turnover
- 0.88
Valuation Ratios
The current PE Ratio of InVitro International is 16.46. InVitro International’s PEG ratio is -0.48.
- PE Ratio
- 16.46
- PS Ratio
- 1.66
- PB Ratio
- 0.75
- Price to FCF
- -11660.09
- Price to Operating Cash Flow
- 313.80
- PEG Ratio
- -0.48
Income Statement
In the last 12 months, InVitro International had revenue of 878.94K and earned 121.98K in profits. Earnings per share was 0.01.
- Revenue
- 878.94K
- Gross Profit
- 718.09K
- Operating Income
- 87.02K
- Pretax Income
- 123.64K
- Net Income
- 121.98K
- EBITDA
- 129.44K
- Earnings Per Share (EPS)
- 0.01
Cash Flow
In the last 12 months, operating cash flow was 4,069 and capital expenditures -4,178, giving a free cash flow of -110 billion.
- Operating Cash Flow
- 4,069
- Free Cash Flow
- -110
- Free Cash Flow per Share
- -0.00
Dividends & Yields
InVitro International pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- >-0.01%
- Earnings Yield
- 4.94%
Stock Price Statistics
- Beta
- -0.62
- 52-Week Price Change
- -32.14%
- 50-Day Moving Average
- 0.06
- 200-Day Moving Average
- 0.08
- Relative Strength Index (RSI)
- 37.57
- Average Volume (3m)
- 30.60K
Financial Position
InVitro International as a current ratio of 12.18, with Debt / Equity ratio of 17.36%
- Current Ratio
- 12.18
- Quick Ratio
- 10.71
- Debt to Market Cap
- 0.05
- Net Debt to EBITDA
- -2.92
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, InVitro International has paid 1,655 in taxes.
- Income Tax
- 1,655
- Effective Tax Rate
- 0.01
Enterprise Valuation
InVitro International EV to EBITDA ratio is 5.58, with an EV/FCF ratio of -2703.13.
- EV to Sales
- 0.39
- EV to EBITDA
- 5.58
- EV to Free Cash Flow
- -2703.13
- EV to Operating Cash Flow
- 73.08
Balance Sheet
InVitro International has $1.23M in cash and marketable securities with $240.30K in debt, giving a net cash position of $985.27K billion.
- Cash & Marketable Securities
- $1.23M
- Total Debt
- $240.30K
- Net Cash
- $985.27K
- Net Cash Per Share
- $0.04
- Tangible Book Value Per Share
- $0.08
Margins
Gross margin is 81.88%, with operating margin of 4.45%, and net profit margin of 8.18%.
- Gross Margin
- 81.88%
- Operating Margin
- 4.45%
- Pretax Margin
- 8.51%
- Net Profit Margin
- 8.18%
- EBITDA Margin
- 6.91%
- EBIT Margin
- 5.61%
Analyst Forecast
The average price target for InVitro International is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- -13.97%
- EPS Growth Forecast
- -47.17%
